Several biologics targeting vascular endothelial growth factor (VEGF) for the treatment of retinal diseases are administered as ITV injections (Jin and Hwang, 2017; Yannuzzi and Freund, 2019). This evidence concerns the gene VEGFA and Abnormal retinal morphology.